More tools:Markets·Screener·Research·Chat

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) Financial Statements

CollPlant Biotechnologies Ltd Ordinary Shares
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI AK-5ECE8E1B70
XNAS · usd
3.58▲ 0.03 (0.85%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close3.55
Day's Range3.30 – 3.69
52-Week Range0.26 – 3.91
Volume195.1K
Avg Volume6.7M
Share Statistics
Shares Outstanding
Employees39
ExchangeXNAS
Listed2021-06-04
Share count as of December 31, 2025
Loading Income Statement…
Key questions about CollPlant Biotechnologies Ltd Ordinary Shares (CLGN)
What is CollPlant Biotechnologies Ltd Ordinary Shares's Market Cap?
CollPlant Biotechnologies Ltd Ordinary Shares's Market Cap is $45.8M, based on as-reported figures from SEC (XBRL) filings.
What is CollPlant Biotechnologies Ltd Ordinary Shares's Price / Sales?
CollPlant Biotechnologies Ltd Ordinary Shares's Price / Sales is 19.3×, based on as-reported figures from SEC (XBRL) filings.
What is CollPlant Biotechnologies Ltd Ordinary Shares's Revenue (TTM)?
CollPlant Biotechnologies Ltd Ordinary Shares's Revenue (TTM) is $2.4M, based on as-reported figures from SEC (XBRL) filings.
What is CollPlant Biotechnologies Ltd Ordinary Shares's Net Income (TTM)?
CollPlant Biotechnologies Ltd Ordinary Shares's Net Income (TTM) is -$11.5M, based on as-reported figures from SEC (XBRL) filings.
What is CollPlant Biotechnologies Ltd Ordinary Shares's EBITDA?
CollPlant Biotechnologies Ltd Ordinary Shares's EBITDA is -$10.6M, based on as-reported figures from SEC (XBRL) filings.
What is CollPlant Biotechnologies Ltd Ordinary Shares's Diluted EPS (TTM)?
CollPlant Biotechnologies Ltd Ordinary Shares's Diluted EPS (TTM) is -0.90, based on as-reported figures from SEC (XBRL) filings.
What is CollPlant Biotechnologies Ltd Ordinary Shares's EBITDA Margin?
CollPlant Biotechnologies Ltd Ordinary Shares's EBITDA Margin is -445.8%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Revenues
YoY growth+360.4%
Cost of revenues
Gross profit (loss)
% of revenue64.8%
Operating expenses:
Research and development
General, administrative and marketing
Total operating loss
% of revenue-484.3%
Financial income (expenses), net
Net loss
% of revenue-484.6%
Basic net loss per ordinary share (in Dollars per share)
Diluted net loss per ordinary share (in Dollars per share)